Literature DB >> 11697469

The esterase-like activity of serum albumin may be due to cholinesterase contamination.

N Chapuis1, C Brühlmann, M Reist, P A Carrupt, J M Mayer, B Testa.   

Abstract

PURPOSE: The "esterase-like activity" of human serum albumin (HSA) is described in the literature, but a contamination of commercially available HSA preparations by plasma cholinesterase is conceivable in some cases. The purpose of the present work was to examine this hypothesis.
METHODS: The hydrolytic activity of HSA and its inhibition by physostigmine were measured fluorimetrically by monitoring the hydrolysis of the ester substrate moxisylyte. Affinity chromatography was used to separate cholinesterase and HSA. The cholinesterase activity in the eluted fractions was assessed using Ellman's reagent and butyrylthiocholine as substrate.
RESULTS: A significant variation in the esterase-like activity of different albumin batches was observed. This activity was strongly inhibited by physostigmine, a well-known inhibitor of cholinesterase. Affinity chromatography led to a complete separation between HSA and the esterase activity, which was found exclusively in the cholinesterase fraction.
CONCLUSIONS: The apparent esterase-like activity of HSA toward moxisylyte and butyrylthiocholine was due to a contamination by cholinesterase. With these substrates, HSA showed a total lack of esterase-like activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11697469     DOI: 10.1023/a:1012204906502

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  23 in total

1.  The esterolytic activity of serum albumin.

Authors:  S B TOVE
Journal:  Biochim Biophys Acta       Date:  1962-02-26

2.  Acetylation of human serum albumin by p-nitrophenyl acetate.

Authors:  G E Means; M L Bender
Journal:  Biochemistry       Date:  1975-11-04       Impact factor: 3.162

3.  Esterase-like activity of human serum albumin toward prodrug esters of nicotinic acid.

Authors:  A Salvi; P A Carrupt; J M Mayer; B Testa
Journal:  Drug Metab Dispos       Date:  1997-04       Impact factor: 3.922

4.  Esterase-like activity of human serum albumin II: reaction with N-trans-cinnamoylimidazoles.

Authors:  N Ohta; Y Kurono; K Ikeda
Journal:  J Pharm Sci       Date:  1983-04       Impact factor: 3.534

5.  Removal of fatty acids from serum albumin by charcoal treatment.

Authors:  R F Chen
Journal:  J Biol Chem       Date:  1967-01-25       Impact factor: 5.157

6.  A naturally occurring molecular form of human plasma cholinesterase is an albumin conjugate.

Authors:  P Masson
Journal:  Biochim Biophys Acta       Date:  1989-10-19

7.  Biochemical characterization of flestolol esterase.

Authors:  C Y Quon; H F Stampfli
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1993-09

8.  The effect of fatty acid chain length on the rate of arylester hydrolysis by various albumins.

Authors:  O S Wolfbeis; A Gürakar
Journal:  Clin Chim Acta       Date:  1987-05-15       Impact factor: 3.786

9.  Acetylation of human serum albumin by acetylsalicylic acid.

Authors:  D Hawkins; R N Pinckard; R S Farr
Journal:  Science       Date:  1968-05-17       Impact factor: 47.728

10.  Nicotinate esters: their binding to and hydrolysis by human serum albumin.

Authors:  A Steiner; J M Mayer; B Testa
Journal:  J Pharm Pharmacol       Date:  1992-09       Impact factor: 3.765

View more
  3 in total

1.  Nongradient blue native gel analysis of serum proteins and in-gel detection of serum esterase activities.

Authors:  Nopporn Thangthaeng; Nathalie Sumien; Michael J Forster; Ruchir A Shah; Liang-Jun Yan
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-12-31       Impact factor: 3.205

2.  Bioreversible derivatives of phenol. 1. The role of human serum albumin as related to the stability and binding properties of carbonate esters with fatty acid-like structures in aqueous solution and biological media.

Authors:  Jesper Østergaard; Claus Larsen
Journal:  Molecules       Date:  2007-10-30       Impact factor: 4.411

Review 3.  Serum paraoxonase 1 (PON1) measurement: an update.

Authors:  Jose J Ceron; Fernando Tecles; Asta Tvarijonaviciute
Journal:  BMC Vet Res       Date:  2014-03-25       Impact factor: 2.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.